To support the above assertion that increased expression of MKP-1 may explain the beneficial effects of β2-agonists/corticosteroid combination therapies in the repression of inflammatory gene expression in asthma [16], we performed in vitro studies measuring secretion of IL-6 and IL-8 from ASM cells after stimulation with TNFα. The gene discussed is IL6; the disease is asthma.